INTRODUCTION
The human body harbors an immense population of harmless bacteria that colonize the gastrointestinal tract soon after birth to reach densities of 10 11 or 10 12 cells per g of luminal contents. Although we typically live in relative harmony with these organisms, it is now well recognized that intestinal homeostasis requires the active generation of mutualistic T-cell responses constituted by a tightly regulated CD4 þ T-cell compartment that includes T helper type 1 (Th1), Th17, and Foxp3 þ regulatory T (Treg) cells. 1, 2 Th17 and Th1 cells are constitutively present in the healthy intestinal mucosa, and activated Foxp3 þ Treg cells are expanded by the presence of intestinal bacteria. 3, 4 These bacterial-induced Treg are critical for preventing inappropriate or exaggerated activation of inflammatory Th1 and/or Th17 responses. 3 Thus, by tightly regulating the different types of CD4 þ T-cell subsets present in the intestine, the host ensures the maintenance of immune homeostasis and thereby prevents detrimental bacterial dissemination from the intestinal lumen to sterile internal organs. 5 Thymic stromal lymphopoietin (TSLP) is an epithelialderived cytokine that was originally isolated in 1994 from a mouse thymic stromal cell line 6 and characterized as a lymphocyte growth factor. 7, 8 It is a 140 amino-acid four-helix bundle cytokine that is closely related to interleukin-7 (IL-7) with which it shares an overlapping but distinct biological profile. 9 TSLP exerts its biological activities by binding to a heterodimeric receptor that consists of the IL-7 receptor a chain (IL-7Ra) and the TSLP receptor (TSLPR) chain, which is closely related to the common cytokine-receptor g chain (gc). TSLPR has low affinity for TSLP but in combination with IL-7Ra generates a high-affinity-binding site for TSLP and triggers signaling through signal transducer and activator of transcription factor 5. 9 TSLP is expressed predominantly by epithelial cells in the thymus, lung, skin, intestine, and tonsils, as well as stromal cells, mast cells, and dendritic cells (DCs). 9, 10 Expression of TSLP is regulated by nuclear factor-kB and can be induced by exposure to viral, bacterial, or parasitic products, inflammatory cytokines, and the Th2 cell-associated cytokines IL-4 and IL-13. [11] [12] [13] [14] [15] [16] TSLP has important roles in conditioning DCs to drive Th2 differentiation 17 and its expression is increased in immunopathologies associated with dysregulated Th2 cell-type cytokine production, including atopic dermatitis 18 and asthma. 19 It has additionally been reported to promote antibody isotype class switching in B cells, 20 to regulate the development of Foxp3 þ Tregs in the human thymus, 19, 21 and to promote basophil hematopoiesis. In the intestine, TSLP has been reported to be constitutively expressed with the highest expression noted in the colon. 11 It has a critical role in the regulation of the inflammatory responses following intestinal damage or helminth infection. 10, 11, 23 Specifically, TSLP was reported to be necessary for protective Th2 immunity following Trichuris muris helminth infection 11, 23 as a result of its ability to limit infection-induced IL-12p40 production. 23 Besides its important role in promoting Th2-dependent immune responses, growing evidence supports a role for TSLP in limiting Th1-and Th17-driven damage in the inflamed intestine.
10,11 TSLPR-deficient specific pathogen-free (SPF) mice develop more severe inflammation and elevated Th1 and Th17 cytokines following dextran sodium sulfate (DSS)-mediated epithelial insult 11 or in a model of CD4 þ T-cell transfer colitis. 10 Furthermore, TSLP is critical in mediating mucosal healing after DSS insult through its ability to stimulate secretory leukocyte peptidase inhibitor expression by intestinal epithelial cells (IECs). 24 We addressed here whether TSLP has a role in regulating intestinal homeostasis under steady-state conditions. We show that TSLP is upregulated in the colon in response to colonization with intestinal bacteria. Bacterial-induced TSLP prevented excessive T-cell IL-17 and interferon-g (IFNg) production, and the absence of TSLP-TSLPR signaling resulted in a notable hyperplasia of colonic lymphoid follicles (LFs). The dysregulated T-cell cytokine response occurred even in the presence of a limited and entirely benign bacterial community, the altered Schaedler flora (ASF), 25 and was associated with a defective expansion of colonic Foxp3 þ Helios À Treg cells upon colonization. These data position TSLP as a key cytokine necessary for the proper generation of mutualistic T-cell responses following colonization of the intestine with a benign bacterial community. RESULTS TSLP expression is elicited by intestinal bacteria and prevents excessive inflammatory cytokine production by T cells TSLP is expressed by both IECs and intestinal DCs, 10, 11 and its expression within the intestine positively correlates with the density of luminal bacteria. 11 Thus, to determine whether intestinal bacteria elicit intestinal TSLP expression, we compared TSLP mRNA levels across different sections of the small and large intestine in SPF mice (harboring a complex diversity of bacterial species) and germ-free mice (raised within a sterile environment with no exposure to intestinal bacteria). In keeping with the literature, TSLP expression was low throughout the small intestine and increased in the colon, peaking within the medial colonic section (Figure 1a) . In contrast to increased TSLP expression in the colon of SPF mice, TSLP expression remained minimal throughout the intestine of germ-free mice, indicating that TSLP expression is upregulated following contact of the large intestinal epithelium with intestinal bacteria and/or their products ( Figure 1a) . We further addressed whether TSLP expression was dependent on the complexity of the commensal flora by analyzing mice colonized with a limited and entirely benign bacterial community, the ASF. 25 As shown in Figure 1b , TSLP is also induced in ASF mice. As TSLP was reported to be expressed by both IECs and DCs, 10, 11 we next compared expression by IEC or lamina propria (LP) and found that while colonic IECs expressed TSLP (Figure 1b) , most of the TSLP mRNA expression was derived from the LP fraction, most probably from DCs ( Figure 1b) . Similar results were also obtained from ASF mice (Figure 1b) . Importantly, the absence of the TSLPR did not impact on TSLP expression by bone marrow-derived DCs, indicating that no positive feedback loop exists for this signaling pathway (Figure 1c) . Taken together, these data showed that intestinal TSLP expression is induced by the commensal flora and is predominately produced by cells located within the LP.
To address whether TSLP expression impacted on intestinal homeostasis in the face of a complex intestinal bacterial community, we analyzed cytokine production by T cells present within the colonic lamina propria (cLP) of SPF TSLPR À / À mice. Although the absence of TSLP-TSLPR signaling did not impact on the total number of CD4 þ or CD8 þ T cells present in the cLP, an increased proportion of CD4 þ T cells were observed to produce the inflammatory cytokine IL-17A (Figure 2a,c) . Reproducible increases in the proportion of CD4 þ T cells and CD8 þ T cells producing IFNg could also be observed, although these never reached statistical significance (Figure 3a) . Previous work identifying colonic APCs using a similar approach indicated that the MPs represent a regulatory IL-10-producing population. 26 The CD11b þ CD103 þ DC population (represented here by the R2 DCs) is thought to represent migratory cells that can act as potent APCs and are characterized by the ability of producing retinoic acid and transforming growth factor-b and inducing de novo differentiation of Tregs. [27] [28] [29] [30] The CD11b À CD103 þ DC population (R3) is thought to represent DCs located in intesitnal lymphoid tissues, most probably the isolated lymphoid follicles (ILFs), 29 while the CD11b þ CD103 À DCs (R1) represent more controversial subset that have been classified either as DCs or as MPs based on their apparent nonmigratory nature and poor antigen-presenting capacity. [27] [28] [29] In our study, no major impact of TSLPR deficiency on the proportion of each investigated subpopulation was noted IL-12p40 is a master regulator of Th1/Th17 differentiation, 31 and TSLP can limit lipopolysaccharide or helminth-elicited IL-12p40 production by DCs. 11, 23, 32 We therefore determined whether TSLPR signaling impacted on the steady-sate production of IL-12p40 in the cLP in response to intestinal bacterial. Analysis of cytokine levels in colon explants, mesenteric lymph node cells, and serum of SPF mice revealed no difference in basal IL-12p40 production in the presence or absence of TSLPR signaling (Figure 2d-f) .
Taken together, these data indicate that TSLP-TSLPR signaling does not impact on the number or functional status of major APC subsets resident in the intestinal colon under steady-state conditions.
TSLPR-deficient mice exhibit hypertrophic development of colonic LFs
We next assessed whether the changes in effector T-cell cytokine production (shown in Figure 2 ) impacted on the overall structure of the colon. In agreement with previous reports, 11 we observed no major histological alterations to the gross colonic architecture of naive TSLPR Figure S2 online). B-cell-rich follicles found within the anterior small intestine and colon can be represented by ILFs formed in response to stimuli derived from luminal Gram-negative bacteria 33 or tertiary lymphoid follicles (tLFs) formed in response to chronic inflammation. 34 Hyperplasia of intestinal LFs has previously been reported for mice exhibiting aberrant production of secretory immunoglobulin A (sIgA), 35 lacking Peyer's Patches 36 or following DSS administration. 34 We therefore checked whether the higher proportion of inflammatory T cells and the increased numbers of LF in the TSLPR À / À mice resulted from alterations in the intestinal microbiota community or an inability to contain the microbiota due to defective humoral immunity. Neither impact of TSLPR signaling was noted for the major bacterial phyla present within the intestine of naive mice (either Gram -ve or Gram þ ve) nor were any defects in sIgA production observed (see Supplementary Figure S3 online). These data are consistent with previous reports 24 and indicate that the enlarged LFs present in TSLPR À / À mice may represent tLFs that developed in response to the dysregulated T-cell response and chronically elevated levels of inflammatory cytokines.
TSLP-TSLPR signaling limits the development of inflammatory CD4
þ T-cell responses following colonization of germ-free mice with a minimal intestinal microbiota
To determine whether the exaggerated inflammatory cytokine production by colonic T cells in TSLPR À / À mice occurred in response to luminal intestinal bacteria, and to rule out the Our earlier experiments showed that altered inflammatory T-cell responses in TSLPR À / À mice were not due to gross changes in local APC populations ( Figure 3 and see Supplementary Figure S1 online), IL-12p40 production (Figure 2) , and protective sIgA or intestinal bacterial communities (see Supplementary Figure S3 online). We therefore hypothesized that the dysregulated effector T-cell responses may arise as a consequence of altered Treg cell function. Helios, an Ikaros transcription factor family member, has been proposed to differentiate thymic-derived from peripherally induced Foxp3 þ Treg cells, 37 although the exact role that Helios has in Treg development remains unclear. Of interest to the current study, it has previously been shown that the majority of Tregs present in the colon of germ-free mice are Helios þ and that bacterial colonization induces a conversion and/or expansion of the Helios À Treg population.
3,4,38
Moreover, bacterial-induced expansion of colonic Foxp3 þ Helios À Treg cells has an essential role in preventing exaggerated Th1 and Th17 responses and is necessary to promote the successful establishment of intestinal homeostasis. 3 Examination of the Foxp3 þ T-cell compartment in TSLPR À / À mice showed that TSLP-TSLPR signaling was necessary for the efficient generation of Foxp3 þ Helios À Treg cells in cLP following ASF colonization ( Figure 5 ). This observed ability of TSLPR signaling to regulate colonic Treg cell phenotype is likely to be responsible for the expansion of Th17 cells in TSLPR À / À mice. By contrast, no differences in the Helios À Treg population were observed in SPF mice in the cLP (see Supplementary Figure S4A online) or MLN (see Supplementary Figure S4B online) probably as a result of the more complex bacterial community masking the impact of TSLP on Treg generation in these mice. Lastly, both the exaggerated inflammatory cytokine production ( Figure 5 ) and the decreased expansion of Foxp3 þ Helios À Treg cells ( Figure 6 ) observed in ASF-colonized TSLPR À / À mice could be replicated following treatment of wild-type C57BL/6J mice with a neutralizing TSLP (clone 28F12) monoclonal antibody throughout the period of ASF colonization (see Supplementary Figure S5 online).
TSLP impacts directly on T cells in response to bacterial colonization
We next investigated the expression levels of IL-7Ra chain and TSLPR chain on FoxP3 À and FoxP3 þ CD4 þ T cells in the cLP and MLN. As shown in Figure 7 , both FoxP3 À and FoxP3
þ T cells at these sites express a functional receptor for 
DISCUSSION
TSLP has recently been shown to have a crucial role in negating overt inflammation in models of pathological colitis. 10, 11 Yet, it has remained unclear whether TSLP also regulates immune reactivity in the healthy steady state in response to colonization with commensal bacteria. In the current study, we investigated the role of TSLP-TSLPR signaling in the maintenance of intestinal homeostasis in mice harboring a complex intestinal microbiota (SPF mice) or following colonization of germ-free mice with a limited, and entirely benign, intestinal microbiota (ASF mice) to reduce the possibility of measuring potential pathobiont-mediated effects. Induction and expansion of colonic Treg cells following ASF colonization of germ-free mice is essential for the maintenance of immune homeostasis and prevents immune deviation exemplified by exaggerated Th1 and Th17 responses. 3 We report a crucial role for the TSLP-TSLPR signaling pathway in mediating intestinal immune homeostasis. Disruption of this pathway, either by genetic TSLPR deficiency or by experimental in vivo TSLP neutralization, resulted in defective expansion of colonic Foxp3 þ Helios À Treg cells and a consequent expansion of Th17 cytokine-producing CD4 þ T cells. Although still controversial, Helios À Tregs are thought to potentially represent bacteria-specific peripherally generated adaptive Treg while Helios þ Treg, which do not seem to be affected by TSLPR deficiency, might represent the more self-reactive thymus-derived natural Treg population. 3, 4 It remains unclear whether disruption of immune homeostasis resulted from defective TSLPR signaling directly on CD4 þ T cells themselves or on innate intestinal cells such as DCs or both. The fact that we did not note an imbalance in major colonic APC populations or in intestinal IL-12p40 production indicates that TSLP may act directly on the T-cell compartment. This view is supported by the expression of a functional TSLPR on both FoxP3
À and FoxP3 þ CD4 þ T cells in the cLP and MLN and by the recent findings of Spadoni et al. 10 who reported that TSLP functions to prevent severe colitis through a direct action on T cells. In support of our own findings, these authors reported a role for DC-derived TSLP in reducing the capacity of in vitro activated CD4 þ T cells to produce IL-17, while fostering the development of Foxp3 þ Treg cells. Furthermore, when we transferred TSLPR À / À and wild-type (CD45.1 þ ) CD4 þ T cells into RAG À / À recipient mice, we noted that an absence of TSLPR signaling directly to T cells led to a reduced expansion of Tregs and an increased production of IL-17A and IFNg.
TSLP has been previously reported to be expressed by colonic epithelial cells or LP DCs in response to bacterial stimulation in vitro. 10, 12, 39 Our study indicates that a LP cell population, probably DCs, represents the predominant source of TSLP production in vivo. Interestingly, TSLP expression required the presence of intestinal bacteria thus providing a feedback loop between the recognition of bacteria, and/or their products, and the regulation of immune homeostasis. TSLP expression by DCs is known to be Myd88 (myeloid differentiation primary response gene 88)-dependent 10 and activation of colonic Treg cells in response to ASF colonization requires Myd88/Ticam signaling.
3 Myd88-dependent TSLP expression may therefore provide a possible link between recognition of commensal bacteria and T-cell homeostasis.
Although TSLPR deficiency resulted in an exaggerated Th1/ Th17 response and reduced expansion of 33 By contrast, formation of tLFs occurs in response to inflammation and is independent of lymphoid tissue inducer cells. Instead chemokines, such as C-X-C motif chemokine ligand 13, are released in response to inflammation and recruit activated lymphotoxin-expressing lymphocytes that interact with lymphotoxin beta receptor-expressing stromal cells to further augment chemokine production and adhesion molecule expression, resulting in a self-sustaining cellular cluster and the formation of an organized lymphoid tissue. 40 Known modulators of ILF formation include bacterial peptidoglycans and sIgA. However, TSLP-TSLPR signaling was not found to impact on bacterial diversity or sIgA production. In contrast to our data, TSLP has previously been reported to promote IgA2 production in humans, 20 thus TSLP-mediated regulation of IgA class switch recombination may represent a crucial difference between the murine and human cytokine.
Although we did not determine the exact nature of the LF present in TSLPR À / À mice, the exaggerated production of T-cell-derived inflammatory cytokines suggests that the observed LFs may represent tLFs. Lipopolysaccharide-elicited T-cell-derived IL-17 production has recently been reported to promote chemokine secretion and tertiary lymphoid tissue development in the lung. 41 Thus exaggerated and chronic IL-17A production may therefore provide a possible explanation for intestinal LF hyperplasia in TSLPR À / À mice. As mentioned, TSLP is known to attenuate DSS-induced colitis. Interestingly, Lochner et al. 34 reported that a hyperplasia of tertiary lymphoid tissues in the intestine predisposed mice to aggravated pathology following DSS administration. Thus increased tLF present in TSLPR-deficient mice may provide one explanation for the increased susceptibility of these animals to pathological colitis. Alternatively, increased colitis may occur as a direct result of the ability of TSLP to regulate T-cell immune deviation. Of note, pathological colitis has previously been associated with reduced TSLP expression in both mice 10 and humans. 32, 42 In conclusion, we have shown that TSLP has a crucial role in the regulation of intestinal immune homeostasis. The absence of TSLP-TSLPR signaling results in immune deviation with exaggerated Th1/Th17 responses and reduced Treg cell activation even in the presence of a limited and benign bacterial community. This study provides the first proof of a role for TSLP in regulating baseline intestinal homeostasis as opposed to inflammatory colitis in vivo and lends support to previous findings associating defective TSLP expression with increased disease severity in Crohn's patients. 32 
METHODS
Mice and treatments. C57BL/6J and C57BL/6J TSLPR À / À 43 mice were bred and maintained at the EPFL animal facility under specific pathogen-free conditions. TSLPR À / À mice were backcrossed to C57BL/6 mice for more than nine generations. Before each experiment, beddings were mixed between all the experimental groups for at least 3-4 weeks. Germ-free C57BL/6 and TSLPR À / À mice were bred and maintained in flexible film isolators at the Clean Mouse Facility of the University of Bern and the Inselspital (Bern, Switzerland). Germ-free status was routinely confirmed by aerobic and anaerobic culture as well as sytox green (Invitrogen, Gaithersburg, MD) and Gram staining (Harleco, EMD Millipore Corporation, Billerica, MA) of cecal contents to detect unculturable organisms. ASF colonization was performed by placing an ASF-colonized mouse into a cage of germ-free animals. Animal experiments were performed according to the institutional guidelines and to Swiss federal and cantonal laws on animal protection. For in vivo neutralization of TSLP, C57BL/6J mice were injected with 200 mg of TSLP-neutralizing antibody (clone 28F12) via the intraperitoneal route twice per week for 4 weeks starting from the day of colonization. Control mice were injected with Rat IgG2a isotype control (clone 2A3, BioXcell, West Lebanon, NH). The 28F12 hybridoma developed by Dr Andrew Farr was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA, USA.
Real-time quantitative PCR. Total RNA was isolated from all intestinal specimens using TRI Reagent (Molecular Research Center, Cincinnati, OH) and reverse transcribed using RevertAid Reverse Transcriptase (Fermentas, Thermo Fisher Scientific, Wohlen, Switzerland). Transcribed cDNA was used as a template for the PCR reaction. Expression was normalized according to the expression of the housekeeping gene b-actin or GAPDH (glyceraldehyde 3-phosphate dehydrogenase). Sequences of primers used: b-actin, Isolation of IECs. IECs were isolated as reported by Kang et al. 44 Briefly, colons were cut into 2-3 -mm fragments and washed by phosphate-buffered saline five times with vigorous shaking. Then, intestines were incubated with 3 mM EDTA and 0.5 mM dithiothreitol at room temperature for 30 min with shaking.
Generation of bone marrow-derived DCs. Bone marrow cells were isolated from naive C57BL/6 or TSLPR À / À mice and bone marrowderived DCs were generated as described by Lutz et al. 45 At day 10, bone marrow-derived DCs were collected and plated out at a concentration of 10 5 cells per well in a 96-well round-bottomed plate. Cells were stimulated with complete medium (IMDM (Iscove's Modified Dulbecco's Medium; BioWhittaker, Lonza, Verviers, Belgium) containing 7% fetal calf serum, L-glutamine, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 100 U ml À 1 penicillin, and 100 mg ml À 1 streptomycin and 25 mM 2-mercaptoethanol (SigmaAldrich, Taufkirchen, Germany)) with or without 1 mg ml À 1 lipopolysaccharide (from Escherichia coli 0111:B4; Sigma-Aldrich) for 3 h.
Mononuclear cell isolation from cLP and MLN. cLP cells were isolated as previously described. 3 Briefly, the colon was flushed, opened longitudinally, washed thoroughly in Mg 2 Cl 2 -and CaCl 2 -free DPBS (Dulbecco's phosphate-buffered saline; GIBCO, Invitrogen). The organs were then cut into 3-5 mm pieces that were incubated 4-5 times in 25 ml EDTA/HEPES/DPBS solution at 37 1C for 20 min in a shaking incubator in order to remove the epithelial layer. Intestinal pieces were collagenase-digested for 40 min at 37 1C in 25 ml IMDM containing 0.5 mg ml À 1 collagenase type VIII (Sigma-Aldrich), 50 U DNaseI (Roche Diagnostic, Nutley, NJ), and 0.01 M HEPES (GIBCO, Invitrogen). The crude cell suspension was loaded onto a 30%/100% percoll (GE Healthcare, Milan, Italy) gradient and centrifuged at 680 g for 30 min at room temperature with the acceleration and brake turned off. Cells were collected from the 30%/100% interphase. MLN were excised and incubated for 10 min at 37 1C with Liberase TL (Roche Diagnostic) and DNaseI (Sigma-Aldrich). The organs were then smashed through a 40-mm cell strainer (BD Biosciences, Franklin Lakes, NJ). Single-cell suspensions were then stained for flow cytometry or stimulated for 4 h in the presence of 50 ng ml À 1 phorbol 12-myristate 13-acetate (Sigma-Aldrich) and 750 ng ml À 1 ionomycin (Invitrogen) with 10 mg ml À 1 Brefeldin A (Sigma-Aldrich) or 2 mM Monensin (Sigma-Aldrich). Cytokine ELISA. To measure IL-12p40, goat anti-mouse antibody (clone C15.6) was used for capture and biotin-conjugated antibody (clone C17.8) followed by alkaline-phosphatase conjugated streptavidin for detection. Recombinant mouse IL-12 was used as standard. All antibodies were purchased from eBioscience.
Histology and immunofluorescence. The colon was prepared using the ''Swiss roll'' technique 46 to evaluate the entire longitudinal section on one slide. For histological evaluation, tissues were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned at 4 mm, stained with haematoxylin and eosin, and examined histologically. For immunofluorescence, tissues were embedded in optimal cutting temperature compound (Tissue-Tek, Sakura Finetek Europe B.V., Alphen aan den Rijn, The Netherlands) and snap frozen in a bath of isopentane on dry ice. In all, 8-mm sections were prepared and stained with IgA FITC (c10-3, BD Bioscience), CD11c PE (N418, eBioscience), B220 alexa 647 (RA3-6B2, Biolegend), and DAPI (Sigma-Aldrich). Lymphoid follicle maturation was assessed depending on the presence of B220 þ cells (low to none: immature follicles, high: mature follicles); size was assessed by visual observation using a Zeiss Axioplan microscope (Carl Zeiss Inc, Thornwood, NJ).
T-cell transfer. Total CD4 þ cells were isolated from the spleen of wildtype CD45.1 or TSLPR À / À with anti-CD4 MACS beads (Miltenyi Biotec, Bergisch Gladbach, Germany). A total of 4 Â 10 6 wild-type and TSLPR À / À cells (1:1 ratio) were transferred to germ-free RAG À / À recipients. ASF colonization was started on the day of T-cell transfer and recipient mice were analyzed after 28 days.
Statistics. Results represent means ± SEM. Statistical significance was determined by the Student's t-test (*Po0.05, **Po0.01, ***Po0.001).
